Upgrade to SI Premium - Free Trial

Armata Pharma (ARMP)

3.20 +0.13 (4.23%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Armata Pharmaceuticals receives two U.S. patents for phage therapies October 7, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States October 7, 2026 7:00 AM - PR NewsWire Form 8-K Armata Pharmaceuticals, For: Sep 23 September 23, 2026 7:10 AM - SEC Filing Armata gets $3.7M from U.S. DoW for AP-SA02 Phase 3 program September 23, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development September 23, 2026 7:00 AM - PR NewsWire H.C. Wainwright Reiterates Buy Rating on Armata Pharmaceuticals (ARMP) September 22, 2026 7:36 AM - StreetInsider Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates September 21, 2026 7:00 AM - PR NewsWire Form 8-K Armata Pharmaceuticals, For: Sep 14 September 14, 2026 7:12 AM - SEC Filing FDA grants Armata Pharmaceuticals breakthrough therapy status for AP-SA02 September 14, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02 September 14, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals publishes phage biology study in molecular journal September 3, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials September 3, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals, Inc. (ARMP) Tops Q2 EPS by 17c August 12, 2026 4:47 PM - StreetInsider Form 10-Q Armata Pharmaceuticals, For: Jun 30 August 12, 2026 4:23 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Aug 12 August 12, 2026 4:17 PM - SEC Filing Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update August 12, 2026 4:05 PM - PR NewsWire Full Article List